These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13691043)

  • 41. [Emergency checklist: subungual hematoma].
    Volkering C; Mathonia P; Delhey P; Kessler S
    MMW Fortschr Med; 2009 Mar; 151(10):37. PubMed ID: 19472666
    [No Abstract]   [Full Text] [Related]  

  • 42. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.
    Galimont-Collen AF; Vos LE; Lavrijsen AP; Ouwerkerk J; Gelderblom H
    Eur J Cancer; 2007 Mar; 43(5):845-51. PubMed ID: 17289377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
    Jiaravuthisan MM; Sasseville D; Vender RB; Murphy F; Muhn CY
    J Am Acad Dermatol; 2007 Jul; 57(1):1-27. PubMed ID: 17572277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alopecia universalis with twenty-nail dystrophy (trachyonychia).
    Chien P; Kovich OI
    Dermatol Online J; 2008 May; 14(5):24. PubMed ID: 18627760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yellow nail syndrome.
    Maldonado F; Ryu JH
    Curr Opin Pulm Med; 2009 Jul; 15(4):371-5. PubMed ID: 19373089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of linear nail growth to treat diseases of the nail.
    Geyer AS; Onumah N; Uyttendaele H; Scher RK
    J Am Acad Dermatol; 2004 Feb; 50(2):229-34. PubMed ID: 14726877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study.
    Tan AL; Benjamin M; Toumi H; Grainger AJ; Tanner SF; Emery P; McGonagle D
    Rheumatology (Oxford); 2007 Feb; 46(2):253-6. PubMed ID: 16837473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation versus neurodegeneration: consequences for treatment.
    Palace J
    J Neurol Sci; 2007 Aug; 259(1-2):46-9. PubMed ID: 17418237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
    Zakeri M; Valikhani M; Mortazavi H; Barzegari M
    Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An effective surgical treatment for nail thickening in Darier's disease.
    Baran R
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):689-91. PubMed ID: 16268871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nail surgery: practical tips and treatment options.
    Jellinek NJ
    Dermatol Ther; 2007; 20(1):68-74. PubMed ID: 17403262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nail disorders in patients with chronic renal failure and undergoing haemodialysis treatment: a case-control study.
    Dyachenko P; Monselise A; Shustak A; Ziv M; Rozenman D
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):340-4. PubMed ID: 17309455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis and management of nail psoriasis].
    Sánchez-Regaña M; Umbert P
    Actas Dermosifiliogr; 2008; 99(1):34-43. PubMed ID: 18206085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
    Rich P; Griffiths CE; Reich K; Nestle FO; Scher RK; Li S; Xu S; Hsu MC; Guzzo C
    J Am Acad Dermatol; 2008 Feb; 58(2):224-31. PubMed ID: 18083272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Shiny nail, spotted nail. Beau-Reil lines. When dermatoses entrench in the nails].
    Weidinger S; Köhn FM; Ring J
    MMW Fortschr Med; 2003 Sep; 145(38):38-40. PubMed ID: 14603680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
    Diluvio L; Campione E; Paternò EJ; Mordenti C; El Hachem M; Chimenti S
    Pediatr Dermatol; 2007; 24(3):332-3. PubMed ID: 17542899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nail manifestations of systemic diseases.
    Herzberg AJ
    Clin Podiatr Med Surg; 2004 Oct; 21(4):631-40, vii. PubMed ID: 15450902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
    Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.